Chitin-based hydrogel loaded with bFGF and SDF-1 for inducing endogenous mesenchymal stem cells homing to improve stress urinary incontinence

Carbohydr Polym. 2023 Nov 1:319:121144. doi: 10.1016/j.carbpol.2023.121144. Epub 2023 Jun 29.

Abstract

Nonoperative treatments for Stress Urinary Incontinence (SUI) represent an ideal treatment method. Mesenchymal stem cell (MSCs) treatment is a new modality, but there is a lack of research in the field of gynecological pelvic floor and no good method to induce internal MSC homing to improve SUI. Herein, we develop an injectable and self-healing hydrogel derived from β-chitin which consists of an amino group of quaternized β-chitin (QC) and an aldehyde group of oxidized dextran (OD) between the dynamic Schiff base linkage.it can carry bFGF and SDF-1a and be injected into the vaginal forearm of mice in a non-invasive manner. It provides sling-like physical support to the anterior vaginal wall in the early stages. In the later stage, it slowly releasing factors and promoting the homing of MSCs in vivo, which can improve the local microenvironment, increase collagen deposition, repair the tissue around urethra and finally improve SUI (Scheme 1). This is the first bold attempt in the field of pelvic floor using hydrogel mechanical support combined with MSCs homing and the first application of chitin hydrogel in gynecology. We think the regenerative medicine approach based on bFGF/SDF-1/chitin hydrogel may be an effective non-surgical approach to combat clinical SUI.

Keywords: Basic fibroblast growth factor; Chitin hydrogel; JAK/STAT signaling pathway; Proteomics; Stem cell chemokine; Stem cell homing.

MeSH terms

  • Animals
  • Chitin / pharmacology
  • Collagen
  • Female
  • Hydrogels / pharmacology
  • Mesenchymal Stem Cells*
  • Mice
  • Urinary Incontinence, Stress* / drug therapy

Substances

  • Hydrogels
  • Chitin
  • Collagen